Lymphocyte transformation and hepatitis. I. Impairment of thymidine incorporation and DNA polymerase activity.
D000410:Alanine Transaminase / Q000032:analysis; D000469:Alkaline Phosphatase / Q000032:analysis; D001219:Aspartate Aminotransferases / Q000032:analysis; D001663:Bilirubin / Q000097:blood; D002478:Cells, Cultured / Q000187:drug effects; D004254:DNA Nucleotidyltransferases / Q000378:metabolism*; D004261:DNA Replication / Q000187:drug effects; D005260:Female; D006506:Hepatitis A / Q000097:blood*; D006511:Hepatitis B Antigens; D006515:Hepatitis B virus; D006801:Humans; D037102:Lectins / Q000494:pharmacology*; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D010759:Phosphorus Isotopes; D013936:Thymidine / Q000378:metabolism*; D014316:Tritium
D006511:Hepatitis B Antigens; D037102:Lectins; D010759:Phosphorus Isotopes; D014316:Tritium; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D004254:DNA Nucleotidyltransferases; D000469:Alkaline Phosphatase; D001663:Bilirubin; D013936:Thymidine